Abingworth LLP

SEC CIK: 0001397144
Latest filing: Feb 10, 2023

SEC filings (opens in a new tab)

XFOR holding history

X4 Pharmaceuticals, Inc in every 13F filed by Abingworth LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

XFOR overview All 13F holders of XFOR Full Q4 2022 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of XFOR by Abingworth LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−229,885−100.0%	Sold out	Holders
Q2 2021	229,885	$1.49M	0.5%	00.0%	Unchanged	Holders
Q1 2021	229,885	$1.96M	0.7%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.